Yale University and Boehringer Ingelheim have partnered to launch a Biomedical Data Science Fellowship program, to be awarded to post-doctoral researchers focused on drug discovery and...
A precision medicine therapy developed by researchers at UCLA and Great Ormond Street Hospital (GOSH) in London restored immune function in more than 95 percent of pediatric patients.
Using the...
Healthcare organizations are increasingly looking to expand their precision medicine and genomics research efforts, with two recent partnerships reflecting the industry’s aim to enhance these...
A study of genomic data in patients with advanced small-cell lung cancer provided new insights into the patterns of treatment resistance, potentially paving the way for precision medicine...
The University of Alabama at Birmingham School of Medicine and UAB Hospital laboratories have launched the Genomic Diagnostics Lab (GDL), an effort to increase genetic testing and advance precision...
NorthShore University HealthSystem has launched a system-wide genomics program that will leverage predictive analytics to improve care for hereditary cancer, cardiovascular diseases, and rare...
In an initial clinical trial, researchers found that a new precision medicine therapy for a common form of congenital blindness was safe and improved patients’ vision, according to a study...
The Pancreatic Cancer Action Network (PanCAN) has launched Precision Promise, a precision medicine clinical trial that will aim to improve pancreatic cancer drugs.
Moores Cancer Center at UC San Diego...
While the healthcare industry has leveraged precision medicine approaches in areas ranging from cancer to Alzheimer’s disease, recently researchers have focused on the potential for targeted...
A new blood test may reveal the biological basis of mood disorders and offer precision medicine approaches to treatment, according to a study published in Molecular Psychiatry.
Mood disorders affect...
NIH is seeking to expand the inclusion of American Indian and Alaska Native (AI/AN) people in the All of Us Research Program, an effort to advance precision medicine treatments for all populations.
In...
Using deep learning and genomic data, researchers from Beaumont Health have discovered a simple blood test that may help predict Alzheimer’s disease in patients.
In a study published in PLOS...
Enhanced data sharing and increased diversity will help accelerate precision medicine efforts and establish a more equitable healthcare industry, according to a new commentary published in Cell.
In...
The emergence of next-generation sequencing technology has led to widespread genomic testing and the availability of genomic data, providing a way for clinicians and patients to better understand...
A newly-developed sensor can evaluate transmissions in the brain at both the microscopic and the nanoscopic level, accelerating Alzheimer’s precision medicine, according to a study published in...
Personalization is something most people have come to appreciate – if not expect – in everyday, consumer-driven experiences.
From recommended movies and shows based on what you’ve watched, to playlists tailored to your...
NIH has launched the next version of the Accelerating Medicines Partnership Alzheimer’s disease program (AMP AD 2.0), an effort to enable precision medicine treatments for Alzheimer’s.
AMP...
An innovative approach helped researchers analyze the role of protein-protein interactions (PPIs) in cases of hypertrophic cardiomyopathy (HCM), a discovery that could advance precision medicine...
In a collaborative study among life sciences companies, oncology providers, and patient advocacy groups, researchers will evaluate up to 12,000 community-based, metastatic non-small cell lung cancer...
To increase precision medicine adoption, healthcare leaders must build education among patients and providers, implement advanced infrastructure, and boost patient engagement, according to a report...
